Use of gene therapy in a subcutaneous murine model of lung cancer;Aplicación de tratamiento génico a un modelo subcutáneo de cáncer de pulmón murino

Archivos de Bronconeumologia

Volumn 42, Issue 10, 2006, Pages 526-532

  Rodrigo Garzón, Manuel ^a,b   Fernández De La Cuesta, Iñigo Tirapu ^a   Arina Iraeta, Ainhoa ^a   Centelles Llorente, Miguel Noel ^a   Zulueta Francés, Javier ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

^b NONE   (Spain)

Author keywords

Adenovirus; Dendritic cells; Gene therapy; Interleukin 12; Lung cancer; Thymidine kinase

Indexed keywords

BETA GALACTOSIDASE; INTERLEUKIN 12; THYMIDINE KINASE;

ADENOVIRUS VECTOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DENDRITIC CELL; FOLLOW UP; GENE THERAPY; IN VIVO STUDY; LEWIS CARCINOMA; LUNG CANCER; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; REPORTER GENE; TUMOR VOLUME; VIRAL GENE DELIVERY SYSTEM;

EID: 33751027446     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13093396     Document Type: Article

References (30)

1. Rubanyi GM. The future of human gene therapy. Mol Aspects Med. 2001;22:113-42.
2. Carter BJ. Gene therapy as drug development. Mol Ther. 2000;1:211-2.
3. Albelda SM, Wiewrodt R, Zuckerman JB. Gene therapy for lung disease: hype or hope? Ann Intern Med. 2000;132:649-60.
4. George JA. Gene therapy progress and prospects: adenoviral vectors. Gene Ther. 2003;10:1135-41.
5. Brown MD, Schätzlein AG, Uchegbu IF. Gene delivery with synthetic (non viral) carriers. Int J Pharm. 2001;229:1-21.
6. Shenk T. Adenoviridae: the viruses and their replication. En: Fields BN, et al. Fundamental virology, Filadelfia: Lippincott-Raven; 1996. p. 2111-71.
7. Giovanni C, Nanni P, Forni G. The prospects for cancer gene therapy. Int J Immunopharmacol. 2000;22:1025-32.
8. Hwang HC, Smythe WR, Elshami AA, Kucharczuk JC, Amin KM, Williams JP, et al. Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer. Am J Respir Cell Mol Biol. 1995;13:7-16.
9. Colombo MP, Trinchieri G. Interleukin-12 in antitumor immunity and immunotherapy. Cytokine & Growth Factor Rev. 2002;13:155-68.
10. Inaba K, Steinman RM, Van Voorhis WC, Muramatsu S. Dendritic cells are critical accessory cells for thymus-dependent antibody responses in mouse and in man. Proc Natl Acad Sci USA. 1983;80 6041-5.
11. Rescigno M, Granucci F, Citterio S, Foti M, Ricciardi-Castagnoli P. Coordinated events during bacteria-induced DC maturation. Immunol Today. 1999;20:200-4.
12. Nishioka Y, Hirao M, Robbins PD, Lotze MT, Tahara H. Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to express interleukin 12. Cancer Res. 1999;59:4035-41.
13. Qian C, Bilbao R, Bruña O, Prieto J. Induction of sensitivity to ganciclovir in human hepatocellular carcinoma cells by adenovirus-mediated gene transfer of herpes simplex virus thymidine kinase. Hepatology. 1995;22:118-23.
14. Mazzolini G, Qian C, Xie X, Sun Y, Lasarte JJ, Drozdzik M, et al. Regression of colon cancer and induction of antitumor immunity by intratumoral injection of adenovirus expressing interleukin-12. Cancer Gene Ther. 1999;6:514-22.
15. Melero I, Duarte M, Ruiz J, Sangro B, Galofré JC, Mazzolini G, et al. Intratumoral injection of bone-marrow derived dendritic cells engineered to produce interleukin-12 induces complete regression of establish murine transplantable colon adenocarcinomas. Gene Ther. 1999;6:1779-84.
16. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37 Suppl 8:4-66.
17. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, et al. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science. 1997;275:1320-3.
18. Wickham TJ, Mathias P, Cheresh DA, Nemerow GR. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 1993;73:309-19.
19. Takayama K, Ueno H, Pei X-H, Nakanishi Y, Yatsunami J, Hara N. The levels of integrin avb5 may predict the susceptibility to adenovirus-mediated gene transfer in human lung cancer cells. Gene Ther. 1998;5:361-8.
20. Batra RK, Olsen JC, Pickles RJ, Hoganson DK, Boucher RC. Transduction of non-small cell lung cancer cells by adenoviral and retroviral vectors. Am J Respir Cell Mol Biol. 1998;18:402-10.
21. Kwong Y-L, Chen S-H, Kosai K, Finegold M, Woo SLC. Combination therapy with suicide and cytokine genes for hepatic metastases of lung cancer. Chest. 1997;112:1332-7.
22. Mesnil M, Yamasaki H. Bystander effect in herpes simplex virus-thymidine kinase/ganciclovir cancer gene therapy: role of gap-junctional intercellular communication. Cancer Res. 2000;60:3989-99.
23. Cusack JC, Spitz FR, Nguyen D, Zhang W-W, Cristiano RJ, Roth JA. High levels of gene transduction in human lung tumors following intralesional injection of recombinant adenovirus. Cancer Gene Ther. 1996;3:245-9.
24. Nagamachi Y, Tani M, Shimizu K, Yoshida T, Yokota J. Suicidal gene therapy for pleural metastasis of lung cancer by liposome-mediated transfer of herpes simplex virus thymidine kinase gene. Cancer Gene Ther. 1999;6:546-53.
25. Cavallo F, Signorelli P, Giovarelli M, Musiani P, Modesti A, Brunda MJ, et al. Antitumor efficacy of adenocarcinoma cells engineered to produce interleukin 12 (IL-12) or other cytokines compared with exogenous IL-12. J Natl Cancer Inst. 1997;89:1049-58.
26. Nasu Y, Bangma CH, Hull GW, Lee HM, Hu J, Wang J, et al. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther. 1999;6:338-49.
27. Sumimoto H, Tani K, Nakazaki Y, Tanabe T, Hibino H, Wu M-S, et al. Superiority of interleukin-12-transduced murine lung cancer cells to GM-CSF or B7-1 (CD80) transfectants for therapeutic antitumor immunity in syngenic immunocompetent mice. Cancer Gene Ther. 1998;5:29-37.
28. Bacon CM, Petricoin EF, Ortaldo JR, Rees RC, Larner AC, Johnston JA, et al. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A. 1995;92:7307-11.
29. Specht JM, Wang G, Do MT, Lam JS, Royal RE, Reeves ME, et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med. 1997;186:1213-21.
30. Roth JA, Grammer SF. Gene replacement therapy for non-small cell lung cancer: a review. Hematol Oncol Clin North Am. 2004;18:215-29.